References
- Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009; 8:784-96.
- Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivorsof childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Fam Med 2004;2:61-70. https://doi.org/10.1370/afm.26
- Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA 2002;287:1832-9. https://doi.org/10.1001/jama.287.14.1832
- Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, et al. Medical care in long-term survivorsof childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2008;26:4401-9. https://doi.org/10.1200/JCO.2008.16.9607
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition: A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469- 80. https://doi.org/10.1111/j.1464-5491.2006.01858.x
- Despr s JP, Lemieux I. Abdominal e obesity and metabolic syndrome. Nature 2006;444:881-7. https://doi.org/10.1038/nature05488
- Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-36. https://doi.org/10.1161/ATVBAHA.107.151092
- Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-14. https://doi.org/10.1016/j.jacc.2006.09.032
- Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol 2007;29:309-14. https://doi.org/10.1097/MPH.0b013e318059c249
- van Waas M, Neggers SJ, van der Lelij AJ, Pieters R, van den Heuvel-Eibrink MM. The Metabolic Syndrome in Adult Survivors of Childhood Cancer, a Review. J Pediatr Hematol Oncol 2010 Mar 11. [Epub ahead of print]
- Ko MS, Kim JY, Lim YJ, Lee YH, An HS, Yoo JH, et al. Patterns of obesity during anticancer chemotherapy in children with acute lymphoblastic leukemia. Korean J Hematol 2008;43:77-82. https://doi.org/10.5045/kjh.2008.43.2.77
- Lee YJ, Kim YH, Hah JO. Prevalence of obesity and cardiovascular risk factors in survivors of childhood acute lymphoblastic leukemia. Korean J Pediatr Hematol Oncol 2003;10:198-205.
- Lee JH, Seo HJ, Kim JY, Ko CW, Lee KS. Late endocrine complications in childhood cancer survivors. Korean J PediatrHematol Oncol 2005;12:55-62.
- Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997;82:2423-8. https://doi.org/10.1210/jc.82.8.2423
- Binnerts A, Deurenberg P, Swart GR, Lamberts SW. Body composition in growth hormone-deficient adults. Am J Clin Nutr 1992;55:918-23.
- de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. Serum lipid levels in growth hormone-deficient men. Metabolism 1994;43:199-203. https://doi.org/10.1016/0026-0495(94)90245-3
- Angelin B, Olivecrona H, Ericsson S, Rudling M. Growth hormone and low-density lipoproteins. Acta Endocrinol 1993;128(Suppl 2):26S8S.
- Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993;13: 296-301. https://doi.org/10.1161/01.ATV.13.2.296
- Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone deficient adults are insulin-resistant. Metabolism 1995;44:1126-9. https://doi.org/10.1016/0026-0495(95)90004-7
- Roman J, Villaizan CJ, Garcia-Foncillas J, Azcona C, Salvador J, Sierrasesumaga L. Chemotherapy-induced growth hormone deficiency in children with cancer. Medical Pediatr Oncol 1995;25:90-5. https://doi.org/10.1002/mpo.2950250208
- Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine sequelae of cancer and cancer treatments. J Cancer Surviv 2007;1:261-74. https://doi.org/10.1007/s11764-007-0038-6
- Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010;28:1308-15. https://doi.org/10.1200/JCO.2008.20.2267
- van Dalen EC, Caron HN, Kremer LC. Prevention of anthracycline-induced cardiotoxicity in children: The evidence. Eur J Cancer 2007;43:1134-40. https://doi.org/10.1016/j.ejca.2007.01.040
- Liles A, Blatt J, Morris D, Wardrop R 3rd, Sharma A, Sznewajs A, et al. Monitoring pulmonary complications in long-term childhood cancer survivors: Guidelines for the primary care physician. Cleve Clin J Med 2008;75:531-9. https://doi.org/10.3949/ccjm.75.7.531
- Bhatia S, Constine LS. Late morbidity after successful treatment of children with cancer. Cancer J 2009;15:174-80. https://doi.org/10.1097/PPO.0b013e3181a58f46
- Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983;36:252-5. https://doi.org/10.1097/00007890-198309000-00005
- Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009;27:2356-62. https://doi.org/10.1200/JCO.2008.21.1920
- Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, et al. Breast cancer and other second neoplasms after childhood Hodgkins disease. N Engl J Med 1996;334:745-51. https://doi.org/10.1056/NEJM199603213341201